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The aim of this study was to investigate the cancer risk that could be incurred from the use of some 
anti-cholera herbal drugs sold in Southwest Nigeria. Three most popular anti-cholera herbal drugs 
were studied. The cancer risk estimation for the drugs at studied population ranges from 7.119 to 
0.338 x 10-8 in children, 9.563 to 0.129 x 10-8 in preteen and 9.541 to 5.196 x 10-8 in adult. The cancer 
risk estimated values are below the USEPA set value 1 x 10-6. This established that the use of these 
herbal drugs might not lead to cancer if consumed at low dosage. 
________________________________________________________________________________ 
Introduction 
Cholera remains a worldwide menace to public 
health. Cholera is an acute disease caused by 
Vibrio choleraea gram-negative bacillus with 
high indisposition and death [1–2].Global record 
shows that about 5 million infections from 
cholera occurs annually which claim the lives of 
about 150,000 affected patient [3]. Cases of 
persistent cholera outbreaks are very rampant in 
most Africa countries, cholera outbreaks in 
Africa has led to high fatality rates.  Estimation 
from the cholera issues report to world health 
organization in the year 1970 to 2012 shows that 
(46%) of the cases are from Africa. In addition, 
in the year 2012, the world documentation on 
cholera infection revealed that sub-Sahara Africa 
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accounted for 71% of cholera infections and 86% 
deaths from cholera tragedy [4, 5]. Nigeria is 
ranked third among the world nations that are 
confronted with cholera foci [6]. The first 
outbreaks of cholera in Nigeria was in between 
the year 1970 to 1990. However, subsequent 
recurrence of cholera outbreaks has taken place 
times without number in Nigeria [6]. In 2010, 
41,787 cases of cholera with 1,716 deaths was 
recorded in 18 northern states of Nigeria with 
4.1% case fatality rate.  The Southern metropolis 
of Nigeria is not left out of cholera outbreaks [7]. 
Diverse measures has been taken to eradicate or 
prevent the outbreak of cholera among which are 
thorough washing of hands with soap and clean 
water before meal, provision of chlorinated 
portable water for domestic and industrial use 
and consumption of well cooked foods[8]. 
Nevertheless, the search for medication to cure 
this infections when they emerge is vital. The 
emergence of multidrug-resistant of Vibrio 
choleraestrains and destructive opinions of 
people towards the use of synthetic antibiotics 
have led to search and development of novel 
antibiotics 9 [9]. The notion of the public on the 
effectiveness and safety of herbal drugs has led 
to increase rate in the use of herbal drugs as 
medication to cure cholera in Nigeria. The 
antimicrobial activity of many medicinal plant 
and herbal drug extracts against Vibrio 
choleraehas been previously stated [10-12]. The 
conviction of  many on the safety and 
effectiveness level of herbal drugs compared to 
synthetic drugs are not always valid as 
pharmaceutical guidelines and scientist 
discoveries has shown that many herbal drugs 
and medicinal plants often contained some 
contaminant such as  concentration of heavy 
metals, pesticide residue and polycyclic aromatic 
hydrocarbons (PAHs)[13,14]. Recently the 
contaminations of herbal drugs with substantial 
amount of cadmium, arsenic, mercury and some 
priority PAHs has been reported [15 ].The 
presences of these toxic substances in herbal 
drugs has been linked to poor storage conditions 
and environmental pollution of farm lands where 
medicinal plants are grown or processed, or 
during [16]. The existence of PAHs in medicinal 
plants and herbal drugs is an issue of great 
challenge that calls for proper assessment and 
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monitoring. Therefore, to guide against this looming 
health problem, the toxicity assessment of these 
herbal drugs must be assess before endorsement for 
sales and use. The aim of this study was to determine 
the toxicity of some randomly selected anti-cholera 
herbal drugs used Nigeria. 
Materials and Method 
Three most popular known anti-cholera herbal 
drugs used in Southwest region of Nigeria were 
bought at different stores. The selection of these 
herbal drugs are due to their efficiency, readily 
availability and high popularity among the 
public. 500 mL bottles of each of the herbal drugs 
samples were used for the study. The description 
of the herbal drug samples are shown in (Table 
1). 
Table 1. Basic description of herbal drug samples. 
Extraction of anti-cholera herbal drug 
samples 
The method of [14] was adopted for the 
extraction of PAHs in the herbal drug samples. 
Fifteen (15) mL of the herbal drug sample was 
measured with a measuring cylinder and was 
transferred into a clean test tube. Four (4) mL of 
analytically grade n-hexane was added to the 
herbal drug sample in the test tube. The test tube 
containing the mixture was place on ultrasonic 
S/N Product name Same code Claimed ingredients Form Dosage form 
1 “Evergreen   Herb” EGH SennaAlata stem and 




2 “Ruzu   Mixture” RZM 
 







3 “Fortified Herbal 
Mixture” 
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bath for 20 minutes for proper extraction. The 
extract was filtered, the filtrate obtained was 
store in clean beaker. Four (4) mL of analytically 
grade acetone was added to the residue in the test 
for ultrasonic extraction for another 20 minutes. 
The extract was filtered and the filtrate obtained 
was added to the filtrate in the beaker. This 
procedure was repeated thrice for all the samples. 
The filtrate was concentrated on a rotary 
evaporator to obtain a crude extract by removing 
the extracting solvent. The crude extract obtained 
was transferred into a cleaned sample bottle and 
store in the refrigerator for further purification 
and analysis.  
Clean-up of the extract. 
Column chromatography was used to purify the 
extract to remove any form of impurities that 
might been extracted alongside with the PAHs. 
One (1) cm wide column was packed with a 
mixture of aluminum oxide and silica gel in ratio 
1:3 acting as the stationary phase using dry 
method of packing a chromatographic column. 
The crude extract was loaded on the packed 
column. The combination of n-hexane and 
acetone at various volume was used as used as a 
mobile phase for eluting the extract. The eluent 
obtained was air dried at room temperature to 
remove the eluting solvents. The obtained eluate 
was analyzed with Gas Chromatography-Flame 
Ionization Detector (GC-FID) to quantify the 
PAHs in the herbal drug samples. Triplicate 
analysis were performed on each of the purified 
extract. 
Chromatographic conditions for (GC-FID) 
Operation 
The operating instructions of the gas 
chromatography (GC) coupled with a flame 
ionization detector (FID) was adhere to as stated 
in the GC- FID using a dimethylpolysiloxane 
OV-5-fused silica capillary column (30 m × 0.25 
mm i.d. × 0.25 μm film thickness) nitrogen gas 
was used as the carrier gas at a flow rate of 1.2 
ml/min, wavelength was 200 nm, temperature of 
column was 45°C, volume of extract injected = 2 
μl; column thickness  was 1meter and the 
detector temperature was 280°C. 
Calculation of the concentration of 
Benzo(a)pyrene toxicity equivalent in the 
anti-diarrhea herbal drug sample 
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The carcinogenic effects associated with a long 
time exposure to the herbal drugs was estimated 
by calculating the standard lifetime risk from the 
concentration of PAHs in the samples with the 
[16] model. Consequently upon this equivalent 
benzo(a)pyrene toxicity was calculated. 
Estimation of toxic equivalent 
Benzo(a)Pyrene concentration 
The model developed by [14, 16] was used to 
calculate B[a]P equivalent from the 
concentrations of carcinogenic PAHs in the 
samples  
TEQ = Σ(PAHi × TEFi)    
   Equation 1 
TEQ = Toxicity equivalence. 
PAHi = Concentration of carcinogenic PAHs in 
each sample 
TEFi = Toxic equivalent factor (potency relative 
to benzo(a)pyrene)  
TEF values as stated by USEPA for 
benzo[a]anthracene, chrysene, 
benzo[b]fluoranthene, benzo[k]fluoranthene, 
benzo[a]pyrene, dibenzo[a,h]anthraceme and 
indeno[1,2,3-c,d]pyrene are 0.1, 0.001, 0.1, 0.01, 
1, 1, and 0.1 respectively [17]. 
Daily Exposure 
The ATSDR equation was modified to determine 
the health risk linked with exposure to 
carcinogenic PAHs in the herbal drugs samples 
by calculating the daily exposure dose [18]. 
Exposure dose = (Concentration × intake rate × 
conversion factor × exposure factor)    equation 
2 
                                                      Weight of the 
body  
 
Dose = estimated exposure dose in (mg/kg/day); 
Intake rate = volume of sample consumed which 
is 0.30L per day;  
Body weight of consumer (children, preteens and 
adults) =  19 kg, 48 kg and 65 kg respectively 
Conversion factor = 10-6 
Exposure factor = (6 times a week per year = 
312/365) 
Concentration = concentration of total toxicity 
equivalent of benzo(a)pyrene.  
Cancer risk evaluation 
The lifetime cancer risk was calculate using 
equation 3 ref [14] 
Cancer risk estimation = (Exposure dose × 
Number of year of sample usage × CPF)   
equation 3 
Average life time of user 
 
CPF = cancer potency factor which is given as 
(7.3)  
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Years of sample intake = 30 years; 
 User’s life time =55 years. 
Results and discussion 
Concentrations of PAHs in the anti-cholera 
herbal drug sample 
The concentration of sixteen (16) individual 
PAHs in the herbal drug samples analyzed is 
shown in (Table 2). Among the analyzed anti-
cholera herbal drugs, BgP had highest 
concentration of 5.402 mg/kg while PYR had the 
lowest concentration of individual PAH (0.111 
mg/kg). The highest concentration of total PAHs 
in the herbal drug samples was found in FHM 
sample with a concentration of (29.524 mg/kg) 
and lowest concentration of total PAHs (15.696 
mg/kg) was detected in RZM herbal drug sample. 
The percentage of carcinogenic PAHs found in 
the herbal drug samples was in the range of 59.81 
to 53.68 %. Sample FHM had highest percentage 
of cariogenic PAHs and sample RZM had lowest 
percentage. The high percentages of 
carcinogenic PAHs observed in this study was 
due to high concentration of carcinogenic PAHs 
in the samples. The presence of PAHs in these 
herbal drug samples might have emanated from 
deposition of PAHs on the medicinal plant’s 
parts or during the combustion of the plants parts 
in the cause of the herbal drugs production [19]. 
The concentration of total PAHs in this study was 
found lower than that report by [20] on some 
herbal teas produced in Polish which ranges from 
112.43 μg/kg to 58.52 μg /kg. However, short 
time usage and low dosage of these drugs are 
recommended to prevent future health 
challenges. 
Diagnostic indices of PAHs in the anti-cholera 
herbal drug samples 
The concentration of PAHs ratios 
calculated from the diagnostic indices via the 
modification of [22] model was employed in 
determination of the sources of PAHs in the 
herbal drug samples. The concentration of 
PHE/ANT ratio calculated for all the herbal drug 
samples   were below 10 The PAHs ratio 
ANT/(ANT+ PHE)  calculated in this study were 
greater than 0.1.  FLT/(FLT+ PYR) ratio in the 
herbal drugs were above 0.4 as showed in (Table 
3). The values of ratio obtained from this 
calculation in an indication that the PAHs in 
these herbal drugs are from pyrogenic source. 
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This is a confirmation that herbal drugs samples 
were expose to combustion in the process of 
production. 
Ring distribution of PAHs in the anti-cholera 
herbal drug samples. 
The number of fused rings in the PAHs structure 
was used to investigate the preliminary toxicity of 
the herbal drugs. PAHs with 2fused rings are 
tagged Low molecular weight PAHs 
(LMWPAHs), those with 3-4 fused rings are 
tagged moderate molecular weight PAHs (MMW 
PAHs) while PAHs with more than 5 fused ring are 
classified high molecular weight PAHs 
(HMWPAHs) .This classification was based on the 
previous study [23]. The increasing order of the 
concentration of PAHs according to the group 
distribution of PAHs in the anti-cholera herbal 
drugs was 
LMWPAHs<MMWPAHs<HMWPAHs for all the 
samples as showed in (Figure 1). PAHs with heavy 
molecular weight have high carcinogenic 
properties compared to light molecular weight 
PAHs [23]. This suggest that the herbal drug 
samples possess high carcinogenic properties due 
to high concentration of heavy molecular weight 
PAHs found in them. Users are therefore warn to 
adhere to low dosage usage of these herbal drugs as 
high dosage and longtime usage might cause 
cancer or other health problems. 
The benzo[a]pyrene equivalents in this study are 
4.4954, 3.3075 and 6.0734 for samples EGH, RZM 
and FHM respectively as showed in (Table 4). 
FHM had highest value of TEQ benzo[a]pyrene 
concentration while sample RZM had lowest 
concentration. Subsequently upon this, the 
calculated TEQ and carcinogenic slope factor 
(CSF) was used as framework to calculate the 
exposure dose used for the assessment of the cancer 
risk incurred from the usage or exposure to these 
herbal drugs. The cancer risk estimation among the 
study populace ranges from 7.119 to 0.338 x 10-8 
in children, 9.563 to 0.129 x 10-8 in preteen and 
9.541 to 5.196 x 10-8 in adult has showed in 
(Figure 3). The exposure dose and estimated 
cancer risk illustrated in (Figure 2 and 3) 
respectively were lower than the recommended 
value (1 x 10-6) to cancer as set by USEPA [24]. 
However, consumer who are persistently exposed 
to high intake of these herbal drugs could have an 
increased risk of having certain form of cancer.
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Table 2. Concentrations of PAHs in the anti-cholera herbal drug sample 




NAP  0.141±0.2 0.431±0.2 0.914±0.3 
 
1.486 
ACY  1.444±0.1 BDL 2.391±0.2  
 
3.835 
ACP  BDL 1.048±0.1 1.115±0.1 
 
2.163 
FLR  1.871±0.1 BDL 0.187±0.6 
 
2.058 
PHE  2.134±0.4 2.565±0.2 0.390±0.5 
 
5.089 
ANT  1.671±0.5 1.333±0.9 0.417±0.2 
 
3.421 
FLT  0.453±0.3 0.874±0.2  0.719±0.3 
 
2.046 
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PYR  0.111±0.3 0.207±0.2 0.312±0.3 
 
0.630 
BaA  1.983±0.1 1.015±0.5 2.054±0.2 
 
5.052 
CHR  2. 512±0.3 0.724±0.4 4.333±0.3 
 
7.569 
BbF  2.604±0.0 1.951±0.1 3.076±0.5 
 
7.631 
BkF  2.157±0.3 0.567±0.2 1.901±0.4 
 
4.625 
BaP  0.251±0.1 2.286±0.3 1.001±0.1 
 
3.538 
DhA  1.053±0.3 0.171±0.1 2.135±0.4 
 
3.359 
IcP  4.240±0.7 1.712±0.3 3.157±0.5 
 
9.109 
BgP  2.129±0.3 0.812±0.1 5.402±0.2 
 
8.343 




 24.754 15.696 29.524 
 
69.954 
Σ Carcinogenic PAHs 14.8 8.426 17.657 40.883 
% Carcinogenic PAHs 59.79 53.68 59.81 58.44 
NAP = Naphthalene, ACY = Acenaphthylene, ACP = Acenaphthene, FLR = Fluorene, PHE = Phanathrene, ANT = 
Anthracene, FLT = Fluoranthene,  PYR = Pyrene, BaA  = Benzo (a) anthracene, CHR = Chrysene, BbF = Benzo (b) 
fluoranthene,  BkF = Benzo (k) fluoranthene, BaP = Benzo (a) pyrene,  DhA = Dibenzo (a,h) anthracene, IcP = Indeno 
(1,2,3-cd) pyrene, BgP = Benzo (g,h,i) perylene  [Carcinogenic PAHs: BaA, BbF, IcP, BkF, CHR, BaP and DhA [19,21] 
] BDL–below detection limit; means ±SD (n =3) 
 
Table 3. Diagnostic indices of PAHs in the anti-cholera herbal drug samples 





EGH RZM FHM 
PHE 
ANT 
1.28 0.00 0.94 < 10   







0.44 0.34 0.52 < 0.1  
> 0.1                        
Petrogenic 





0.80 0.81 0.70 < 0.4   
> 0.4                           
Petrogenic 
Pyrogenic     
Pyrogenic 
 
PHE = Phanathrene, ANT = Anthracene, FLT = Fluoranthene and PYR = Pyrene 
  





Figure 1. Group distribution of PAHs in the anti-cholera herbal drug samples 
 
Table 4. Toxicity Equivalent (TEQ) of benzo[a]pyrene concentration (mg/kg) in anti-cholera herbal drugs 
Sample BaA BbF IcP BkF CHR BaP DhA Total Bap 
TEQ 
TEF 0.1 0.001 0.1 0.01 1 1 0.1  
EGH 0.1983 0.0026 0.4240 0.0022 2. 512 1.251 0.1053 4.4954 
RZM 0.1015 0.0020 0.1712 0.0057 0.724 2.286 0.0171 3.3075 















2 3 4 5 6 TPAHs
Sample   FHM 0,914 4,5 7,418 8,133 8,559 29,524
Sample   RZM 0,431 4,946 2,82 4,975 2,524 15,696

























sample FHM 8,4888 3,2446 2,3961
sample RZM 1,6229 1,767 1,3049

















Figure 3. Estimated cancer risk for the anti-cholera herbal drug samples 
Conclusion 
 
Despite the acclaimed efficacy of the anti-
cholera drugs studied the preliminary 
toxicological assessment of these herbal drugs 
revealed high concentration of heavy molecular 
weight PAHs, high concentration of carcinogenic 
PAHs which might lead to some health 
challenge. However, the cancer risk estimation 
among the studied populace in this study 
confirmed that exposure to these herbal drugs 
cannot  produce any cancerous infections judging 
from the cancer risk value that is  below the 
standard set by USEPA for carcinogenic 
occurrence. Low dosage and short time usage of 
this drugs are recommended for the public as 
excessive exposure can be dangerous to human 
health. Moreover, more scientific and 
pharmacological investigation, assessment and 
monitoring of herbal drugs should be ensured to 
prevent future health challenges.            
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